Skip to content
Research Article Open access

Investigation of Low Bioavailability Using Physiologically Based Pharmacokinetic Modeling: A Case Example (Lassbio-596)

Manuela de Lima Toccafondo Vieira, Lídia Moreira Lima, Eliezer J. Barreiro, Carlos Alberto Tagliati

Current Journal of Applied Science and Technology · pp. 613–620 · Published 24 Nov 2014

10.9734/BJAST/2015/13527

Abstract

Aim: Investigate the possible mechanism (s) of the poor bioavailability of a lipophilic compound in rats using the physiologically based pharmacokinetic (PBPK) modeling approach. Methodology: A rat PBPK model was constructed using data from intravenous administration, and verified by comparing predicted tissue concentrations (kidneys, liver and lungs) with experimental data from tissue distribution studies. Using parameter sensitivity analysis, the model was used to investigate the absorption characteristics of the compound and the probable causes of the low absorbed fraction. Results: Sensitivity analysis of absorption parameters was performed to understand the absorption characteristic of the compound in regard to permeability, solubility and intra-gut degradation. Taking in consideration the latter factor, the oral pharmacokinetics of the tested compound was satisfactorily predicted in rats. Conclusion: The PBPK simulation results suggest that chemical or/and bacterial degradation of the compound in the gastrointestinal tract may be a probable cause of the low bioavailability observed.

Physiologically-based pharmacokinetic pharmacokinetic bioavailability modeling

References (15)

  1. 1 The gastrointestinal microbiota as a site for the biotransformation of drugs [DOI]
  2. 2 Population-Based Mechanistic Prediction of Oral Drug Absorption [DOI]
  3. 3 A Priori Prediction of Tissue:Plasma Partition Coefficients of Drugs to Facilitate the Use of Physiologically‐Based Pharmacokinetic Models in Drug Discovery [DOI]
  4. 4 A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES [DOI]
  5. 5 A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of ‘Bottom-Up’ vs ‘Top-Down’ Recognition of Covariates [DOI]
  6. 6 Prediction of Intestinal First-Pass Drug Metabolism [DOI]
  7. 7 Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction [DOI]
  8. 8 PBPK models for the prediction of in vivo performance of oral dosage forms [DOI]
  9. 9 Intestinal efflux transporters and drug absorption [DOI]
  10. 10 Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies [DOI]
  11. 11 From preclinical to human – prediction of oral absorption and drug–drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example [DOI]
  12. 12 Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in-vivo performance of solid oral dosage forms [DOI]
  13. 13 Development and Application of an Automated Solution Stability Assay for Drug Discovery [DOI]
  14. 14 A physiologically based pharmacokinetic model of alvespimycin in mice and extrapolation to rats and humans [DOI]
  15. 15 Predictive approaches to increase absorption of compounds during lead optimisation [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

58

Page views

0

PDF downloads

24

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.